News headlines about PerkinElmer (NYSE:PKI) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. PerkinElmer earned a news impact score of 0.19 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 47.0707017890393 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the headlines that may have impacted Accern’s scoring:

PerkinElmer (NYSE PKI) traded down $0.04 during mid-day trading on Thursday, reaching $79.54. 584,469 shares of the company traded hands, compared to its average volume of 560,875. The stock has a market cap of $8,655.98, a P/E ratio of 22.09, a PEG ratio of 1.89 and a beta of 0.77. PerkinElmer has a 52 week low of $50.59 and a 52 week high of $79.89. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Friday, January 19th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, January 18th. PerkinElmer’s dividend payout ratio is presently 7.78%.

Several equities research analysts have recently weighed in on PKI shares. Robert W. Baird increased their target price on shares of PerkinElmer from $75.00 to $78.00 and gave the company an “outperform” rating in a research note on Friday, November 3rd. Zacks Investment Research raised shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 target price on the stock in a research note on Monday, January 8th. Morgan Stanley increased their target price on shares of PerkinElmer from $77.00 to $78.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Jefferies Group reissued a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research note on Friday, October 20th. Finally, Goldman Sachs Group reissued a “neutral” rating and issued a $67.00 target price on shares of PerkinElmer in a research note on Tuesday, September 26th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the stock. PerkinElmer presently has a consensus rating of “Hold” and an average price target of $72.29.

In other PerkinElmer news, insider Andrew Okun sold 12,680 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $72.00, for a total transaction of $912,960.00. Following the transaction, the insider now owns 25,121 shares of the company’s stock, valued at approximately $1,808,712. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Frank Anders Wilson sold 37,535 shares of the firm’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $70.14, for a total transaction of $2,632,704.90. The disclosure for this sale can be found here. Insiders sold a total of 86,336 shares of company stock worth $6,114,917 in the last ninety days. 2.20% of the stock is currently owned by insiders.

WARNING: “PerkinElmer (PKI) Earns Coverage Optimism Rating of 0.19” was reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/01/18/perkinelmer-pki-earns-coverage-optimism-rating-of-0-19.html.

About PerkinElmer

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.